Group name
Non-Neoadjuvant HT Group
Age
67.5 (49–77)
Age remark
median (IQR)
PSA
7.3 (0.97-93)
PSA remark
Initial PSA (ng/mL)
low
84 (20.6%)
intermediate
164 (40.2%)
high
160 (39.2%)
Risk remark
D’Amico risk classification